The effect of administration of fibrinogen in decreasing bleeding in cesarean section.

The effect of prophylactic administration of intravenous fibrinogen to reduce bleeding during cesarean section

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120910010800N8

Enrollment

105

Registered

2022-11-11

Start date

2022-12-11

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum hemorrhage. Postpartum hemorrhage

Interventions

Intervention 1: Intervention group: After performing spinal anesthesia, one vial of fibrinogen powder equivalent to one gram of it under the brand name HAEMOCOMPLETTAN P Injection, Powder 1 g made by

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Consent to the study

Exclusion criteria

Exclusion criteria: Drug abuse Existence of uncontrolled underlying disease Recent history of coagulation disease Taking drugs that affect blood clotting before hospitalization

Design outcomes

Primary

Measure	Time frame
Bleeding during surgery. Timepoint: End of surgery. Method of measurement: The amount of bleeding during the operation will be measured by gas count and suction measurement, as well as the estimation of bleeding at the operation site by an anesthesiologist.	—

Secondary

Measure	Time frame
Number of units of injected blood products. Timepoint: 24 hours after surgery. Method of measurement: Registration of blood products injection sheet.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDariush Abtahi

Shahid Beheshti University of Medical Sciences

drdariushabtahi@yahoo.com+98 21 2263 2611

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026